CureSHANK Logo (IMAGE) CureSHANK Caption Parents of children affected by Phelan-McDermid syndrome (PMS) announce CureSHANK, a nonprofit organization focused on accelerating drug development in PMS and other diseases related to the SHANK genes for which there are currently no FDA approved treatments. As one of a small handful of known monogenic causes of autism, PMS presents an excellent launch pod to develop disease-modifying therapies not only for the syndrome but also for other SHANK related diseases and forms of autism. Credit CureSHANK Inc. Usage Restrictions None License Licensed content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.